Neuraxis (NRXS) Price to Sales (2023 - 2025)

Neuraxis has disclosed Price to Sales across 3 years of filings, most recently posting 49.96 for Q4 2025.

• In Q4 2025, Price to Sales rose 131.48% year-over-year to 49.96; the TTM figure through Dec 2025 stood at 13.55 (up 121.55% YoY), while the FY2025 annual figure was 13.55, up 121.55% from the prior year.
• Price to Sales came in at 49.96 for Q4 2025 at Neuraxis, up from 37.53 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 49.96 in Q4 2025 to a low of 16.34 in Q4 2023.
• Average Price to Sales over 3 years is 29.24, with a median of 29.98 recorded in 2023.
• The largest YoY upside for Price to Sales was 131.48% in 2025 against a maximum downside of 45.56% in 2025.
• Over 3 years, Price to Sales stood at 16.34 in 2023, then surged by 32.08% to 21.58 in 2024, then soared by 131.48% to 49.96 in 2025.
• Per Business Quant data, the three most recent Price to Sales figures were 49.96 in Q4 2025, 37.53 in Q3 2025, and 26.68 in Q2 2025.